EndoVascular Aortic Repair With Sac Embolization for the Prevention of Type II Endoleaks (the EVAR-SE Study)
NCT ID: NCT05665101
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2023-01-15
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary interventions to treat T2EL often fail and may be highly invasive. Various risk factors for T2EL have been described. This enables prediction whether a patient is at high risk for T2EL after EVAR. Deployment of metal coils in the aneurysm sac as part of the EVAR procedure can reduce the risk for T2EL.The present study aims to assess the efficacy of sac embolization during EVAR to prevent T2EL.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-emptive Abdominal Aortic Aneurysm Sac Embolization During EVAR
NCT05575570
AI-enhanced Imaging Analysis to Predict Post-EVAR
NCT06592105
Endovascular Abdominal Aortic Aneurysm Repair by Interventional Cardiologists
NCT01452620
Endovascular Aortic Repair of Free and Contained Ruptured Thoraco-Abdominal Aortic Aneurysm
NCT05956873
Secondary Intervention and Surveillance After EVAR
NCT05335642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EVAR with SE
Patients in the EVAR-SE arm will receive EVAR with additional coil embolization of the aneurysm sac.
Coil embolization of aneurysm sac
Patients are treated with standard EVAR with additional coiling of the aneurysm sac. The distinct type of coils used is not predefined.
standard EVAR
Patients in the standard EVAR arm will receive EVAR without additional coil embolization of the aneurysm sac.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coil embolization of aneurysm sac
Patients are treated with standard EVAR with additional coiling of the aneurysm sac. The distinct type of coils used is not predefined.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infrarenal AAA ≥50 mm maximum diameter
* Indication for EVAR within IFU of company
* Presence of one or both high risk criteria on CT-A: ≥5 patent efferent vessels (inferior mesenteric and/or lumbar artery, and/or median sacral artery) or \<40% thrombus at largest AAA diameter
Exclusion Criteria
* Fenestrated or branched EVAR
* Concomitant iliac artery aneurysm
* Non-ability to adhere to the FU protocol
* Lack of consent
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technical University of Munich
OTHER
St. Josefs-Hospital Wiesbaden GmbH
OTHER
University Hospital Augsburg
OTHER
University Hospital Carl Gustav Carus
OTHER
Christoph Knappich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Knappich
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Knappich, PD Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Technical University Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TUM Klinikum Rechts der Isar, Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Knappich C, Kirchhoff F, Fritsche MK, Egert-Schwender S, Wendorff H, Kallmayer M, Haller B, Hyhlik-Duerr A, Reeps C, Eckstein HH, Trenner M. Endovascular aortic repair with sac embolization for the prevention of type II endoleaks (the EVAR-SE study): study protocol for a randomized controlled multicentre study in Germany. Trials. 2024 Jan 2;25(1):17. doi: 10.1186/s13063-023-07888-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01KG2128
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
V1.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.